Tauriga Sciences Receives Tens of Thousands of Dollars Worth of Purchase Orders from International / Kosher Distributor(s)
December 26 2019 - 10:05AM
InvestorsHub NewsWire
NEW YORK, NY -- December 26, 2019 --
InvestorsHub NewsWore -- Tauriga Sciences, Inc. (OTCQB: TAUG)
(“Tauriga” or the“Company”), a revenue generating Company that
operates through the development, distribution, and licensing of
proprietary products as well as the evaluation of potential
acquisition opportunities and equity investments, today announced
it has received Tens of Thousands of Dollars worth of Purchase
Orders from multiple International / Kosher
Distributors. These Purchase Orders have been received by the
Company, as a result of the Exhibitor Booth (# 7095) that it
operated at Kosherfest 2019 – which took place on November 12-13,
2019 in Secaucus, New Jersey. The Company has already
received payment(s) and shipped product, concerning a substantial
portion of the above-mentioned Purchase Orders. The
Company expects to realize this revenue, in connection with these
above-referenced Purchase Orders, during both its current Quarter
(October 1, 2019 – December 31, 2019) and its next Quarter (January
1, 2020 – March 31, 2020).
Moving forward, the Company continues to experience
strong levels of interest from a broad array of additional
International Distributors. Most notably the Company is
currently in late stage negotiations with a major United Kingdom
(“UK” or “England”) based Kosher Distributor and is hopeful to
receive an initial Purchase Order in the near term. The
Company is also in discussions with International Distributors,
from the following countries: Australia, Israel, France, Malaysia,
Aruba, Barbados, and
Canada.
ABOUT TAURIGA SCIENCES
INC.
Tauriga Sciences, Inc. (TAUG) is a revenue
generating Company that operates through the development,
distribution, and licensing of proprietary products as well as the
evaluation of potential acquisition opportunities. One such
opportunity on which the Company has acted, involves the Company
having entered into the cannabidiol (or “CBD”) infused chewing gum
product business, as more fully described above and in prior press
releases. This CBD infused chewing gum product has been
branded under the following name: Tauri-Gum™. The
Company is currently in production of three distinct flavors of
Tauri-Gum™: MINT, BLOOD ORANGE, and POMEGRANATE. On
December 6, 2019 the Company announced that it completed the
initial production run (thereby expanding its existing product
lines) with the introduction of a 25mg Vegan CBD Isolate Infused
vegan gummy (“gum drop”), branded under the name:
Tauri-Gummies™. Further, the Company continues to
identify and evaluate additional potential opportunities to
generate revenue, as well as shareholder value, and leverage its
resources and expertise to build a diversified and sustainable
business model. Please visit our corporate website
at www.tauriga.com.
In addition, on March 11, 2019, the Company
announced the official launch of its E-Commerce site - as part of
its Tauri-Gum™ commercialization strategy. This site can be
accessed by visiting the following URL
address: www.taurigum.com
The Company has established corporate offices in
both New York City (USA) and Barcelona
(Spain).
DISCLAIMER -- Forward-Looking
Statements
This press release contains certain
“forward-looking statements” as defined by the Private Securities
Litigation Reform Act of 1995 which represent management’s beliefs
and assumptions concerning future events. These forward-looking
statements are often indicated by using words such as “may,”
“will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or
plans, and may include statements regarding corporate objectives as
well as the attainment of certain corporate goals and milestones.
Forward-looking statements are based on present circumstances and
on management’s present beliefs with respect to events that have
not occurred, that may not occur, or that may occur with different
consequences or timing than those now assumed or anticipated.
Actual results may differ materially from those expressed in
forward looking statements due to known and unknown risks and
uncertainties, such as are not guarantees of general economic and
business conditions, the ability to successfully develop and market
products, consumer and business consumption habits, the ability to
consummate successful acquisition and licensing transactions,
fluctuations in exchange rates, and other factors over which
Tauriga has little or no control. Many of these risks and
uncertainties are discussed in greater detail in the “Risk Factors”
section of Tauriga’s Form 10-K and other filings made from time to
time with the Securities and Exchange Commission. Such
forward-looking statements are made only as of the date of this
release, and Tauriga assumes no obligation to update
forward-looking statements to reflect subsequent events or
circumstances. You should not place undue reliance on these
forward-looking statements.
Contact:
CONTACT INFORMATION
Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY 10022
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
cell # (917) 796 9926
Corp.
Website: www.tauriga.com
E-Commerce
Website: www.taurigum.com
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Apr 2023 to Apr 2024